We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

24 hedge funds and large institutions have $4.2M invested in Microbot Medical in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

10% more capital invested

Capital invested by funds: $3.84M → $4.2M (+$365K)

7.57% more ownership

Funds ownership: 11.3% → 18.87% (+7.6%)

4% more funds holding

Funds holding: 23 → 24 (+1)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$2.86M
2
Osaic Holdings
Osaic Holdings
Arizona
+$8.31K
3
TRCT
Tower Research Capital (TRC)
New York
+$7.49K
4
UBS Group
UBS Group
Switzerland
+$3.99K
5
BlackRock
BlackRock
New York
+$622

Top Sellers

Rank Fund Capital Flow
1
SPIA
Steward Partners Investment Advisory
New York
-$19.9K
2
CAN
Cetera Advisor Networks
California
-$6.84K
3
Morgan Stanley
Morgan Stanley
New York
-$6.43K
4
Renaissance Technologies
Renaissance Technologies
New York
-$4.56K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$544
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$2.08M +$2.86M +690,000 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$812K +$544 +131 +0%
BlackRock
3
BlackRock
New York
$458K +$622 +150 +0.1%
AA
4
AlphaCentric Advisors
Puerto Rico
$301K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$159K -$544 -131 -0.2%
Morgan Stanley
6
Morgan Stanley
New York
$109K -$6.43K -1,550 -4%
State Street
7
State Street
Massachusetts
$78.5K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$54K -$4.56K -1,100 -6%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$46.8K -$481 -116 -0.7%
CAN
10
Cetera Advisor Networks
California
$33.1K -$6.84K -1,648 -13%
Northern Trust
11
Northern Trust
Illinois
$31.4K – – –
SPIA
12
Steward Partners Investment Advisory
New York
$17.5K -$19.9K -4,800 -45%
TRCT
13
Tower Research Capital (TRC)
New York
$11K +$7.49K +1,806 +94%
Osaic Holdings
14
Osaic Holdings
Arizona
$9K +$8.31K +2,002 +219%
UBS Group
15
UBS Group
Switzerland
$4.72K +$3.99K +962 +159%
Wells Fargo
16
Wells Fargo
California
$563 -$253 -61 -25%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$278 +$17 +4 +0%
BCM
18
Bourgeon Capital Management
Connecticut
$39 – – –
Bank of America
19
Bank of America
North Carolina
$30 +$33 +8 +400%
Barclays
20
Barclays
United Kingdom
$3 – – –
NFSG
21
Newbridge Financial Services Group
Florida
$3 – – –
Fidelity Investments
22
Fidelity Investments
Massachusetts
$3 +$4 +1 New
NA
23
NewEdge Advisors
Louisiana
– +$4 +1 New

MBOT Hedge Fund Activity: Q4 2022 in Review

24 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2022, worth a combined $4.2M — up 9.5% from $3.84M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MBOT positions and 1 closed out — a net gain of 2 holders — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $2.86M. The largest seller was Steward Partners Investment Advisory, cutting an estimated $19.9K.

  • 24 institutional investors held Microbot Medical (MBOT) as of Q4 2022, up from 23 in Q3 2022.
  • Funds reported $4.2M of Microbot Medical stock for Q4 2022, up 9.5% quarter-over-quarter.
  • 3 funds opened new Microbot Medical positions in Q4 2022 and 1 closed out, a net change of +2 holders.
  • The largest Microbot Medical buyer in Q4 2022 was Armistice Capital, an estimated $2.86M added.
  • The largest Microbot Medical seller in Q4 2022 was Steward Partners Investment Advisory, an estimated $19.9K sold.

Based on aggregated 13F filings for Q4 2022.